{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:50:36Z","timestamp":1793922636697,"version":"4.8.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100022824","name":"Sanofi Pasteur MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ymgme.2026.110114","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T16:54:52Z","timestamp":1775494492000},"page":"110114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Over ten years of newborn screening for LSDs in Tuscany (Italy): Epidemiology, novel variants, and the pseudodeficiency burden"],"prefix":"10.1016","volume":"148","author":[{"given":"Sabrina","family":"Malvagia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Daniotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Tonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Ombrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Forni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Scolamiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Funghini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Falliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Paoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Mura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Raspini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Poggiali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giusi","family":"Scaturro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Sacchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Alice","family":"Donati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Procopio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Guerrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Morrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"la Marca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.ymgme.2026.110114_bb0005","first-page":"1","article-title":"Lysosomal storage diseases","volume":"2","author":"Ferreira","year":"2017","journal-title":"Transl. Sci. Rare Dis."},{"issue":"24","key":"10.1016\/j.ymgme.2026.110114_bb0010","doi-asserted-by":"crossref","first-page":"476","DOI":"10.21037\/atm.2018.11.39","article-title":"Lysosomal storage disease overview","volume":"6","author":"Sun","year":"2018","journal-title":"Ann. Transl. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110114_bb0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13023-017-0733-y","article-title":"Failure to shorten the diagnostic delay in two ultra-orphan diseases (mucopolysaccharidosis types i and III): potential causes and implications","volume":"13","author":"Kuiper","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"issue":"7","key":"10.1016\/j.ymgme.2026.110114_bb0020","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/archdischild-2020-319040","article-title":"Improvement in time to treatment, but not time to diagnosis, in patients with mucopolysaccharidosis type i","volume":"106","author":"Giugliani","year":"2021","journal-title":"Arch. Dis. Child."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2026.110114_bb0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ymgme.2022.07.010","article-title":"An expert consensus on practical clinical recommendations and guidance for patients with classic Fabry disease","volume":"137","author":"Germain","year":"2022","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110114_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00439-006-0280-4","article-title":"New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy","volume":"121","author":"Beck","year":"2007","journal-title":"Hum. Genet."},{"issue":"6","key":"10.1016\/j.ymgme.2026.110114_bb0035","doi-asserted-by":"crossref","first-page":"e1116","DOI":"10.1542\/peds.2008-3667","article-title":"Pompe disease in infants: improving the prognosis by newborn screening and early treatment","volume":"124","author":"Chien","year":"2009","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.ymgme.2026.110114_bb0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ymgme.2013.11.015","article-title":"Early initiation of enzyme replacement therapy for the mucopolysaccharidoses","volume":"111","author":"Muenzer","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110114_bb0045","series-title":"Enzyme-Replacement Therapies for Lysosomal Storage Diseases","volume":"12","author":"Ratko","year":"2013"},{"issue":"4","key":"10.1016\/j.ymgme.2026.110114_bb0050","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.gim.2021.12.013","article-title":"Measurement of lysosomal enzyme activities: a technical standard of the American college of medical genetics and genomics (ACMG)","volume":"24","author":"Strovel","year":"2022","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110114_bb0055","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/ijns6010004","article-title":"Newborn screening for pompe disease in Illinois: experience with 684,290 infants","volume":"6","author":"Burton","year":"2020","journal-title":"Int. J. Neonatal Screen."},{"key":"10.1016\/j.ymgme.2026.110114_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1221140","article-title":"An analysis of pompe newborn screening data: a new prevalence at birth, insight and discussion","volume":"11","author":"Colburn","year":"2024","journal-title":"Front. Pediatr."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110114_bb0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/ijns10010003","article-title":"Light and shadows in newborn screening for lysosomal storage disorders: eight years of experience in Northeast Italy","volume":"10","author":"Gragnaniello","year":"2023","journal-title":"Int. J. Neonatal Screen."},{"issue":"7","key":"10.1016\/j.ymgme.2026.110114_bb0070","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.ekir.2023.04.009","article-title":"Population frequency of undiagnosed fabry disease in the general population","volume":"8","author":"Kermond-Marino","year":"2023","journal-title":"Kidney Int. Rep."},{"issue":"7","key":"10.1016\/j.ymgme.2026.110114_bb0075","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/GIM.0b013e3181a87867","article-title":"Long-term monitoring of patients with infantile-onset pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker","volume":"11","author":"Young","year":"2009","journal-title":"Genet. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110114_bb0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ymgme.2020.04.006","article-title":"A comprehensive testing algorithm for the diagnosis of fabry disease in males and females","volume":"130","author":"Stiles","year":"2020","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2026.110114_bb0085","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/cge.13936","article-title":"Accuracy diagnosis improvement of fabry disease from dried blood spots: enzyme activity, lyso-Gb3 accumulation and GLA gene sequencing","volume":"99","author":"Delarosa-Rodr\u00edguez","year":"2021","journal-title":"Clin. Genet."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110114_bb0090","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10545-009-9036-3","article-title":"Dermatan sulfate and heparan sulfate as a biomarker for mucopolysaccharidosis i","volume":"33","author":"Tomatsu","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110114_bb0095","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/ijns6010010","article-title":"Incorporation of second-tier biomarker testing improves the specificity of newborn screening for mucopolysaccharidosis type i","volume":"6","author":"Peck","year":"2020","journal-title":"Int. J. Neonatal Screen."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110114_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.63940","article-title":"Long-term health outcomes of individuals with pseudodeficiency alleles in IDUA may inform newborn screening practices for mucopolysaccharidosis type i","volume":"197","author":"Grady","year":"2025","journal-title":"Am. J. Med. Genet. A"},{"issue":"1","key":"10.1016\/j.ymgme.2026.110114_bb0105","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/ajmg.a.61930","article-title":"Mucopolysaccharidosis type i newborn screening: importance of second tier testing for ethnically diverse populations","volume":"185","author":"Bosfield","year":"2021","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2026.110114_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2023.113644","article-title":"First three years\u2019 experience of mucopolysaccharidosis type-I newborn screening in California","volume":"263","author":"Fillman","year":"2023","journal-title":"J. Pediatr."},{"issue":"15","key":"10.1016\/j.ymgme.2026.110114_bb0115","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.1021\/ac900504s","article-title":"New strategy for the screening of lysosomal storage disorders: the use of the online trapping-and-cleanup liquid chromatography\/mass spectrometry","volume":"81","author":"la Marca","year":"2009","journal-title":"Anal. Chem."},{"issue":"6","key":"10.1016\/j.ymgme.2026.110114_bb0120","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1255\/ejms.1257","article-title":"Screening of lysosomal storage disorders: application of the online trapping-and-cleanup liquid chromatography\/mass spectrometry method for mucopolysaccharidosis i","volume":"19","author":"Ombrone","year":"2013","journal-title":"Eur. J. Mass Spectrom. (Chichester)"},{"issue":"2","key":"10.1016\/j.ymgme.2026.110114_bb0125","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbadis.2009.11.003","article-title":"Functional studies of new GLA gene mutations leading to conformational fabry disease","volume":"1802","author":"Filoni","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2026.110114_bb0130","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cca.2018.11.001","article-title":"LC-MS\/MS method for simultaneous quantification of heparan sulfate and dermatan sulfate in urine by butanolysis derivatization","volume":"488","author":"Forni","year":"2019","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.ymgme.2026.110114_bb0135","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1086\/339431","article-title":"Alternative splicing in the alpha-galactosidase a gene: increased exon inclusion results in the Fabry cardiac phenotype","volume":"70","author":"Ishii","year":"2002","journal-title":"Am. J. Hum. Genet."},{"issue":"11","key":"10.1016\/j.ymgme.2026.110114_bb0140","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/ejhg.2008.109","article-title":"Unbalanced GLA mRNAs ratio quantified by real-time PCR in fabry patients\u2019 fibroblasts results in fabry disease","volume":"16","author":"Filoni","year":"2008","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2026.110114_bb0145","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cca.2015.10.027","article-title":"Pitfalls in the detection of gross gene rearrangements using MLPA in Fabry disease","volume":"452","author":"Ferri","year":"2016","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.ymgme.2026.110114_bb0150","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"ACMG laboratory quality assurance committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2026.110114_bb0155","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1542\/peds.2016-0280E","article-title":"Pompe disease newborn screening working group management of confirmed newborn-screened patients with Pompe disease across the disease spectrum","volume":"140","author":"Kronn","year":"2017","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.ymgme.2026.110114_bb0160","first-page":"45","article-title":"Prevalence of fabry disease in male dialysis patients: Argentinean screening study","volume":"48","author":"Frabasil","year":"2019","journal-title":"JIMD Rep."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110114_bb0165","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ajmg.c.31998","article-title":"Newborn screening for fabry disease in Oregon: approaching the iceberg of A143T and variants of uncertain significance","volume":"190","author":"Viall","year":"2022","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"issue":"17","key":"10.1016\/j.ymgme.2026.110114_bb0170","doi-asserted-by":"crossref","first-page":"9139","DOI":"10.3390\/ijms25179139","article-title":"Mutation spectrum of GAA gene in Pompe disease: current knowledge and results of an Italian study","volume":"25","author":"Moschetti","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110114_bb0175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/ijns6010009","article-title":"The first year experience of newborn screening for Pompe disease in California","volume":"6","author":"Tang","year":"2020","journal-title":"Int. J. Neonatal Screen."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110114_bb0180","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ymgme.2017.09.008","article-title":"Insight into the phenotype of infants with Pompe disease identified by newborn screening with the common c.-32-13T>G \u201clate-onset\u201d GAA variant","volume":"122","author":"Rairikar","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110114_bb0185","article-title":"Biochemical and genetic testing of GAA in over 30.000 symptomatic patients suspected to be affected with Pompe disease","volume":"22","author":"Balendran-Braun","year":"2024","journal-title":"Hum. Mutat."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110114_bb0190","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1212\/01.wnl.0000252798.25690.76","article-title":"Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype","volume":"68","author":"Kroos","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ymgme.2026.110114_bb0195","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ymgme.2012.04.013","article-title":"Algorithm for Pompe disease newborn screening: results from the Taiwan screening program","volume":"106","author":"Chiang","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"8","key":"10.1016\/j.ymgme.2026.110114_bb0200","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/gim.2017.190","article-title":"Moonlighting newborn screening markers: the incidental discovery of a second-tier test for Pompe disease","volume":"20","author":"Tortorelli","year":"2018","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110114_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2025.101604","article-title":"Reduction of false-positive results with biochemical second-tier testing for newborn screening of Pompe disease","volume":"28","author":"Khoja","year":"2026","journal-title":"Genet. Med."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110114_bb0210","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ymgme.2012.09.024","article-title":"Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types i, II and III","volume":"107","author":"de Ruijter","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110114_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107698","article-title":"Newborn screening for the full set of mucopolysaccharidoses in dried blood spots based on first-tier enzymatic assay followed by second-tier analysis of glycosaminoglycans","volume":"140","author":"Herbst","year":"2023","journal-title":"Mol. Genet. Metab."},{"issue":"8","key":"10.1016\/j.ymgme.2026.110114_bb0220","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/ejhg.2008.34","article-title":"p.[G576S; E689K]: pathogenic combination or polymorphism in Pompe disease?","volume":"16","author":"Kroos","year":"2008","journal-title":"Eur. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110114_bb0225","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ymgme.2009.12.014","article-title":"Genetic heterozygosity and pseudodeficiency in the pompe disease newborn screening pilot program","volume":"99","author":"Labrousse","year":"2010","journal-title":"Mol. Genet. Metab."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226003975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226003975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:59:20Z","timestamp":1787669960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719226003975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1096719226003975"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110114","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Over ten years of newborn screening for LSDs in Tuscany (Italy): Epidemiology, novel variants, and the pseudodeficiency burden","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110114","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110114"}}